Trumab 440 mg Injection
  1. Home
  2. Pharma Products
  3. Glenmark Pharmaceuticals Ltd
  4. Trumab 440 mg Injection

Trumab 440 mg Injection

Trumab 440 mg Injection contains trastuzumab 440 mg and is a targeted anticancer medicine used for HER2-positive cancers. It is supplied as a vial and administered by intravenous infusion under the supervision of a qualified healthcare professional. Trastuzumab targets the HER2 protein on cancer cells, helping inhibit their growth and survival.

BUY NOW

Category

Trumab is a monoclonal antibody used in appropriate treatment regimens for HER2-positive breast cancer and HER2-positive gastric or gastroesophageal junction cancers. By binding to the HER2 receptor, trastuzumab interferes with signaling pathways that promote cancer-cell growth. The dose and infusion schedule are determined by the treating oncologist according to the cancer type and treatment protocol. Cardiac function and other clinical parameters may require monitoring because trastuzumab can cause infusion reactions and potentially affect heart function.

Technical Specification

Specification Details
Active Ingredient Trastuzumab
Strength 440 mg
Dosage Form Injection
Pack Size 1 vial
Route of Administration Intravenous infusion
Manufacturer Glenmark Pharmaceuticals Ltd

Product Also Known As

Trumab 440mg Injection, Trumab 440mg Vial, Trumab 440mg Infusion, Trastuzumab 440mg Injection, Trastuzumab 440mg Infusion, Trastuzumab 440mg Vial